Mechanisms of action of metformin with special reference to cardiovascular protection

Management guidelines continue to identify metformin as initial pharmacologic antidiabetic therapy of choice for people with type 2 diabetes without contraindications, despite recent randomized trials that have demonstrated significant improvements in cardiovascular outcomes with newer classes of an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab Res Rev
Main Authors: Zilov, Alexey V., Abdelaziz, Sulaf Ibrahim, AlShammary, Afaf, Al Zahrani, Ali, Amir, Ashraf, Assaad Khalil, Samir Helmy, Brand, Kerstin, Elkafrawy, Nabil, Hassoun, Ahmed A.K., Jahed, Adel, Jarrah, Nadim, Mrabeti, Sanaa, Paruk, Imran
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Review Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6851752/
https://ncbi.nlm.nih.gov/pubmed/31021474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3173
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados